Maternal-Fetal Medicine Division (Placenta Program), Department of Obstetrics & Gynaecology, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
Department of Pathology and Laboratory Medicine, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
BJOG. 2024 Oct;131(11):1515-1523. doi: 10.1111/1471-0528.17837. Epub 2024 May 9.
To identify which components of maternal vascular malperfusion (MVM) pathology are associated with adverse pregnancy outcomes and to investigate the morphological phenotypes of MVM placental pathology and their relationship with distinct clinical presentations of pre-eclampsia and/or fetal growth restriction (FGR).
Retrospective cohort study.
Tertiary care hospital in Toronto, Canada.
Pregnant individuals with low circulating maternal placental growth factor (PlGF) levels (<100 pg/mL) and placental pathology analysis between March 2017 and December 2019.
Association between each pathological finding and the outcomes of interest were calculated using the chi-square test. Cluster analysis and logistic regression was used to identify phenotypic clusters, and their association with adverse pregnancy outcomes. Cluster analysis was performed using the K-modes unsupervised clustering algorithm.
Preterm delivery <34 weeks of gestation, early onset pre-eclampsia with delivery <34 weeks of gestation, birthweight <10th percentile (small for gestational age, SGA) and stillbirth.
The diagnostic features of MVM most strongly associated with delivery <34 weeks of gestation were: infarction, accelerated villous maturation, distal villous hypoplasia and decidual vasculopathy. Two dominant phenotypic clusters of MVM pathology were identified. The largest cluster (n = 104) was characterised by both reduced placental mass and hypoxic ischaemic injury (infarction and accelerated villous maturation), and was associated with combined pre-eclampsia and SGA. The second dominant cluster (n = 59) was characterised by infarction and accelerated villous maturation alone, and was associated with pre-eclampsia and average birthweight for gestational age.
Patients with placental MVM disease are at high risk of pre-eclampsia and FGR, and distinct pathological findings correlate with different clinical phenotypes, suggestive of distinct subtypes of MVM disease.
确定母体血管功能不全(MVM)病理的哪些成分与不良妊娠结局相关,并研究 MVM 胎盘病理的形态表型及其与子痫前期和/或胎儿生长受限(FGR)不同临床表现的关系。
回顾性队列研究。
加拿大多伦多的一家三级保健医院。
2017 年 3 月至 2019 年 12 月期间,母体循环胎盘生长因子(PlGF)水平低(<100pg/mL)且存在胎盘病理分析的孕妇。
使用卡方检验计算每个病理发现与感兴趣结局之间的关联。使用 K-模式无监督聚类算法进行聚类分析和逻辑回归,以确定表型聚类及其与不良妊娠结局的关系。
早产<34 周,早发型子痫前期伴早产<34 周,出生体重<第 10 百分位数(小于胎龄儿,SGA)和死胎。
与早产<34 周最相关的 MVM 诊断特征是:梗死、绒毛加速成熟、绒毛远端发育不良和蜕膜血管病变。确定了 MVM 病理的两个主要表型聚类。最大的聚类(n=104)的特点是胎盘质量减少和缺氧缺血性损伤(梗死和绒毛加速成熟),与子痫前期和 SGA 合并有关。第二个主要聚类(n=59)的特点是梗死和绒毛加速成熟单独存在,与子痫前期和平均胎龄出生体重有关。
患有胎盘 MVM 疾病的患者有发生子痫前期和 FGR 的高风险,并且不同的病理发现与不同的临床表型相关,提示 MVM 疾病有不同的亚型。